FY2023 Earnings Forecast for Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Issued By HC Wainwright
Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report) – Equities researchers at HC Wainwright cut their FY2023 earnings estimates for shares of Terns Pharmaceuticals in a research note issued to investors on Thursday, November 16th. HC Wainwright analyst E. Arce now anticipates that the company will post earnings per share of ($1.27) for the year, down […]
Source: defenseworld.net
